Vimarsana
Biggest News Aggregation in the World

Page 17 - Vitro Diagnostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Vitro Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Vitro Diagnostics Today - Breaking & Trending Today

Contrasting Artivion (NYSE:AORT) & Surmodics (NASDAQ:SRDX) - Vimarsana News

Contrasting Artivion (NYSE:AORT) & Surmodics (NASDAQ:SRDX)

Surmodics (NASDAQ:SRDX – Get Free Report) and Artivion (NYSE:AORT – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, analyst recommendations, dividends, earnings, risk, valuation and institutional ownership. Profitability This table compares Surmodics and Artivion’s net margins, […]

Source: wkrb13.com
Triple-Negative Breast Cancer Treatment Market Size to Surpass US$ 20 Billion by 2030 - Vimarsana News

Triple-Negative Breast Cancer Treatment Market Size to Surpass US$ 20 Billion by 2030

NEW YORK, United States, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled "Triple-Negative Breast Cancer Treatment Market By Drug Type (Cyclophosphamide, Paclitaxel,

BIOMEDevice Boston To Focus on Emerging MedTech Through Innovation ... - Vimarsana News

BIOMEDevice Boston To Focus on Emerging MedTech Through Innovation ...

BIOMEDevice Boston To Focus on Emerging MedTech Through Innovation ...

Snap Up These 4 Top-Performing Liquid Stocks for Solid Gains – 24/7 Wall St. - Vimarsana News

Snap Up These 4 Top-Performing Liquid Stocks for Solid Gains – 24/7 Wall St.

Stocks with high liquidity levels have always been in demand, owing to their potential to provide maximum returns.

Surmodics (NASDAQ:SRDX) Reaches New 52-Week High at $39.41 - Vimarsana News

Surmodics (NASDAQ:SRDX) Reaches New 52-Week High at $39.41

Surmodics, Inc. (NASDAQ:SRDX – Get Free Report) shares reached a new 52-week high on Monday . The company traded as high as $39.41 and last traded at $38.25, with a volume of 76704 shares. The stock had previously closed at $38.36. Wall Street Analyst Weigh In A number of research analysts recently issued reports on […]